SIMULTANEOUS BILATERAL CAROTID STENTING: A SINGLE CENTRE EXPERIENCE
DOI:
https://doi.org/10.47144/phj.v53i3.1817Abstract
Objective: To evaluate the efficiency, reliability and complications of simultaneous bilateral carotid artery stenting in patients with atherosclerotic bilateral carotid artery stenosis.
Methodology: We analyzed 14 consecutive patients who underwent simultaneous bilateral carotid stenting from September 2010 to January 2016, retrospectively. Clinical outcomes at 30 days and one year after stenting, including hyperperfusion syndrome, haemodynamic depression, minor and major stroke, myocardial infarction and death, were assessed.
Results: The patients were 43 to 73 (62.3 ± 8.8) years old, and 8 (57.1%) were male. Carotid stenting procedure success rate was 100%. Distal embolic protection devices were used in all patients. Up to 30 days after carotid artery stenting, the haemodynamic depression rate was 21.4% (3/14). There were no deaths, minor and major strokes, cases of hyperperfusion syndrome or myocardial infarctions within 30 days. One patient died of septic shock seven months after carotid artery stenting. There were no minor and major strokes or myocardial infarctions within one year.
Conclusion: The data showed that simultaneous bilateral carotid stenting is a technically feasible and reliable alternative treatment method in a selected group of patients with bilateral carotid artery disease.
Downloads
Published
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/